Virbac SA (FRA:V16)
359.50
-3.50 (-0.96%)
At close: Dec 1, 2025
Virbac Company Description
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
The company offers a range of vaccines, antibiotics, parasiticides, and anti-inflammatory drugs, as well as dermatology, dental, specialty, diagnosis, nutrition, petfood, and pharmaceutical products.
It serves veterinarians, farmers, and pet owners. The company was founded in 1968 and is headquartered in Carros, France.
Virbac SA
| Country | France |
| Founded | 1968 |
| Industry | Biological Products, Except Diagnostic Substances |
| Employees | 6,365 |
| CEO | Paul Martingell |
Contact Details
Address: 13e rue LID - BP 27 Carros, 06511 France | |
| Phone | 33 4 92 08 71 00 |
| Website | corporate.virbac.com |
Stock Details
| Ticker Symbol | V16 |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Paul Martingell | Chief Executive Officer |
| Habib Ramdani | Chief Financial Officer |
| Sophie Favini | Chief Operating Officer |